SCHEMBL1532582

SCHEMBL1532582

CC1OC(=O)OC1C[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362334 0.83
SCHEMBL1394595 0.80
SCHEMBL5014546 0.80
SCHEMBL1394489 0.80
SCHEMBL235716 0.80
SCHEMBL6526682 0.78
SCHEMBL15593856 0.78
SCHEMBL2900825 0.78
SCHEMBL5986831 0.78
SCHEMBL1973714 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736489-A1 COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES Cellworks Research India Private Limited (IN) 2014-06-04 EP claimed
WO-2013016718-A1 COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES CELLWORKS RESEARCH INDIA PRIVATE LIMITED (IN) 2013-01-31 WO claimed
CN-1063747-C Quinolone- and naphthyridonecarboxylic acid derivatives BAYER AG (DE) 2001-03-28 CN claimed
CN-1126211-A Quinolone- and naphthyridonecarboxylic acid derivatives BAYER AG (DE) 1996-07-10 CN claimed
EP-0157963-B1 6H-DIBENZ (B,E)(1,4)OXATHIEPIN COMPOUNDS MERCK & CO. INC. (US) 1989-06-21 EP claimed
US-4582842-A Anti-asthmatic 6H-dibenz-[b,e] [1,4]oxathiepin derivatives, compositions, and method of use therefor MERCK & CO., INC. (US) 1986-04-15 US claimed
EP-0166257-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1986-01-02 EP claimed
EP-0157963-A1 6H-dibenz (b,e)(1,4)oxathiepin compounds MERCK & CO. INC. (US) 1985-10-16 EP claimed
EP-3075738-B1 GLYCYRRHETINIC ACID DERIVATIVE AND USE THEREOF INI CORP (JP) 2019-02-13 EP disclosed
US-9796751-B2 Glycyrrhetinic acid derivative and use thereof INI CORPORATION (JP) 2017-10-24 US disclosed
US-20160376303-A1 GLYCYRRHETINIC ACID DERIVATIVE AND USE THEREOF INI CORPORATION (JP) 2016-12-29 US disclosed
EP-3075738-A1 GLYCYRRHETINIC ACID DERIVATIVE AND USE THEREOF INI CORPORATION (JP) 2016-10-05 EP disclosed
EP-2607362-B1 Piperidine and piperazine carboxylates as FAAH inhibitors ASTELLAS PHARMA INC (JP) 2014-12-31 EP disclosed
EP-2736489-A1 COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES Cellworks Research India Private Limited (IN) 2014-06-04 EP disclosed
US-4699917-A Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin derivatives, compositions, and method of use therefor MERCK & CO., INC. (US) 1987-10-13 US disclosed
EP-0233155-A1 Aminoacyloxymethyl compounds CIBA-GEIGY AG (CH) 1987-08-19 EP disclosed
US-4656165-A Aminomethyl penem compounds CIBA-GEIGY CORPORATION (US) 1987-04-07 US disclosed
US-4582842-A Anti-asthmatic 6H-dibenz-[b,e] [1,4]oxathiepin derivatives, compositions, and method of use therefor MERCK & CO., INC. (US) 1986-04-15 US disclosed
EP-0171362-A1 Aminoalkyl penem compounds CIBA-GEIGY AG (CH) 1986-02-12 EP disclosed
EP-0166257-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1986-01-02 EP disclosed